Copyright
©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1643-1658
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1643
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1643
Figure 7 Vascular endothelial growth factor B regulates glucagon secretion via PI3K/AKT signal pathway and relative genes.
A: The protein expression of IR, insulin resistance substrate (IRS), PI3K, p-PI3K, AKT, and p-AKT; B: The protein expression of IR/β-actin; C: The protein expression of IRS/β-actin; D: The protein expression of p-PI3K/PI3K; E: The protein expression of p-AKT/AKT; F: The mRNA expression of forkhead box protein O1, PEPCK, and G6Pase. aP < 0.05 vs standard diet; bP < 0.05 vs high-fat diet-WT; cP < 0.05 vs Con. HFD: High-fat diet; AAV: Adeno-associated virus; SD: Standard diet; IRS: Insulin resistance substrate; FOXO: Forkhead box protein O1.
- Citation: Li YQ, Zhang LY, Zhao YC, Xu F, Hu ZY, Wu QH, Li WH, Li YN. Vascular endothelial growth factor B improves impaired glucose tolerance through insulin-mediated inhibition of glucagon secretion. World J Diabetes 2023; 14(11): 1643-1658
- URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1643.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1643